Volume 48, Issue 2 pp. 157-165
MAIN TEXT

Long-term predictors of morbidity and mortality in patients following LVAD replacement

Fabian Jimenez Contreras

Corresponding Author

Fabian Jimenez Contreras

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Division of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, Florida, USA

Correspondence

Fabian Jimenez Contreras, Division of Thoracic and Cardiovascular Surgery, University of Florida, Gainesville, FL, USA.

Email: [email protected]

Search for more papers by this author
Jess David Rames

Jess David Rames

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Division of Plastic Surgery, Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA

Search for more papers by this author
Jacob Schroder

Jacob Schroder

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Search for more papers by this author
Stuart D. Russell

Stuart D. Russell

Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA

Search for more papers by this author
Jason Katz

Jason Katz

Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA

Search for more papers by this author
Tariq Omer

Tariq Omer

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Search for more papers by this author
Yaron D. Barac

Yaron D. Barac

Division of Cardiovascular and Thoracic Surgery, Rabin Medical Center, Petach-Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Search for more papers by this author
Carmelo Milano

Carmelo Milano

Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA

Search for more papers by this author
First published: 10 October 2023

Abstract

Background

As heart transplant guidelines evolve, the clinical indication for 73% of durable left ventricular assist device (LVAD) implants is now destination therapy. Although completely magnetically levitated LVAD devices have demonstrated improved durability relative to previous models, LVAD replacement procedures are still required for a variety of indications. Thus, the population of patients with a replaced LVAD is growing. There is a paucity of data regarding the outcomes and risk factors for those patients receiving first-time LVAD replacements.

Methods

The study cohort consisted of all consecutive patients between 2006 and 2020 that received a first-time LVAD replacement at a single institution. Preoperative clinical and laboratory variables were collected retrospectively. The primary endpoint was death or need for an additional LVAD replacement. Data were subjected to Kaplan–Meier, univariate, and multivariate Cox hazard ratio analyses.

Results

In total, 152 patients were included in the study, of which 101 experienced the primary endpoint. On multivariate analysis, patients receiving HeartMate 3 (HM3) LVADs as the replacement device showed superior outcomes (HR 0.15, 95% CI 0.065–0.35, p < 0.0001). Independent risk factors for death or need for additional replacement included preoperative extracorporeal membrane oxygenation (ECMO) (HR 4.44, 95% CI 1.87–14.45, and p = 0.00042), increased number of sternotomies (HR 5.20, 95% CI 1.87–14.45, and p = 0.0016), and preoperative mechanical ventilation (HR 1.98, 95% CI 1.01–3.86, and p = 0.045).

Conclusions

Replacement with HM3 showed superior outcomes compared to all other pump types when controlling for both initial pump type and other independent predictors of death or LVAD replacement. Preoperative ECMO, mechanical ventilation, and multiple sternotomies also increased the odds for death or the need for subsequent replacement.

CONFLICT OF INTEREST STATEMENT

No disclosures.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.